Doug joined Symphony Health in 2019 after more than 20 years in the life sciences business and nearly 10 years at PRA Health Sciences. With his diverse background in consulting, analytics, and CRO services, he is focused on bringing innovative offerings and partnerships to the market. Prior to Symphony, Doug held several business development leadership positions at PRA. His last role was Senior Vice President, Global Business of PRA’s Product Registration and Real-World Solutions divisions. During his tenure, sales grew 75% in the US and 33% globally, surpassing $1.5 billion in sales. Prior to joining PRA, Doug was the Global Vice President of Business Development for Octagon Research (now Accenture) and Head of US Business Development for MDS Pharma Services’ (now Syneos) Global Clinical Development Division.
Doug holds a Bachelor of Science degree in Health Care Management from Southern Illinois University and a Master’s in Health Administration from Tulane University.
“We leverage data rapidly to guide patients to the best treatment options possible. The intersection of information and clinical science is an exciting frontier that will ultimately lead to people being able to effectively – and preventatively – manage their health.”